Navamedic ASA (OSL:NAVA)

Norway flag Norway · Delayed Price · Currency is NOK
22.20
-0.30 (-1.33%)
Oct 24, 2025, 2:43 PM CET
-1.33%
Market Cap539.58M
Revenue (ttm)523.56M
Net Income (ttm)-32.38M
Shares Out23.98M
EPS (ttm)-1.85
PE Ration/a
Forward PE28.39
Dividendn/a
Ex-Dividend Daten/a
Volume12,607
Average Volume265,061
Open22.10
Previous Close22.50
Day's Range22.00 - 22.70
52-Week Range17.10 - 31.50
Beta0.31
RSI55.37
Earnings DateOct 28, 2025

About Navamedic ASA

Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally. The company’s product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic and propioni... [Read more]

Sector Healthcare
Founded 2002
Employees 42
Stock Exchange Oslo Børs
Ticker Symbol NAVA
Full Company Profile

Financial Performance

In 2024, Navamedic ASA's revenue was 531.44 million, an increase of 3.80% compared to the previous year's 512.00 million. Losses were -5.49 million, -59.92% less than in 2023.

Financial Statements

News

There is no news available yet.